医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

感染症

Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology

Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology

バイオテクノロジーヘルスケア医療機器感染症病院臨床試験　 TimeLine: Seqirus Announces Next Major Advancement Vaccine Technology

2017年06月21日

0

Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay

Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay

ヘルスケア医療機器感染症　 TimeLine: Quidel Receives PMDA Approval for Its

2017年05月25日

0

Sharklet Technologies宣布被Peaceful Union收购，新的伙伴关系将加快应用Sharklet®的医疗器械及表面技术的开发

Sharklet Technologies宣布被Peaceful Union收购，新的伙伴关系将加快应用Sharklet®的医疗器械及表面技术的开发

バイオテクノロジーヘルスケア医療機器感染症　 TimeLine: Sharklet Technologies宣布被Peaceful 加快应用Sharklet®的

2017年05月20日

0

Company Profile for Laurus Labs Limited

ヘルスケア感染症腫瘍学製薬　 TimeLine: Company Profile for Laurus Labs Limited

2017年05月19日

0

Sharklet Technologies Announces Acquisition by Peaceful Union and New Partnership to Accelerate Development of Medical Devices and Surface Technologies Featuring Sharklet®

Sharklet Technologies Announces Acquisition by Peaceful Union and New Partnership to Accelerate Development of Medical Devices and Surface Technologies Featuring Sharklet®

バイオテクノロジーヘルスケア医療機器感染症　 TimeLine: Partnership to Accelerate Development of Medical Sharklet Technologies Announces Acquisition Technologies Featuring Sharklet

2017年05月18日

0

World’s Foremost Forensic DNA Experts, Scientists and Law Enforcement to Gather October 2-5 in Seattle for the 2017 International Symposium on Human Identification

World’s Foremost Forensic DNA Experts, Scientists and Law Enforcement to Gather October 2-5 in Seattle for the 2017 International Symposium on Human Identification

バイオテクノロジーヘルスケア医療機器感染症製薬遺伝学　 TimeLine: Human Identification Scientists and Law Enforcement to Gather October 2-5 in Seattle for World's Foremost Forensic DNA Experts

2017年05月10日

0

Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic

Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic

バイオテクノロジーヘルスケアヘルス一般感染症製薬　 TimeLine: and Praha Vaccines a.s Nanotherapeutics Bohumil s.r.o Transfer of Human Vaccine Manufacturing Enterprise

2017年05月02日

0

Samsung Bioepis Obtains First Drug Approval in the United States, as the U.S. Food and Drug Administration Approves RENFLEXIS™ (Infliximab-abda) Across All Eligible Indications

Samsung Bioepis Obtains First Drug Approval in the United States, as the U.S. Food and Drug Administration Approves RENFLEXIS™ (Infliximab-abda) Across All Eligible Indications

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: Across All Eligible Indications Food and Drug Administration Approves RENFLEXIS Infliximab-abda Samsung Bioepis Obtains First Drug Approval

2017年04月24日

0

Shionogi presents New Data on Cefiderocol (S-649266), a Siderophore Cephalosporin, and S-033188 a Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza at ECCMID 2017

Shionogi presents New Data on Cefiderocol (S-649266), a Siderophore Cephalosporin, and S-033188 a Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza at ECCMID 2017

ヘルスケアヘルス一般感染症臨床試験　 TimeLine: a Siderophore and S-033188 a Cap-Dependent Endonuclease Shionogi presents New Data on Cefiderocol Treatment of Influenza at ECCMID 2017

2017年04月18日

0

Ansell Launches VivaGel® Condom in Canada

Ansell Launches VivaGel® Condom in Canada

AIDS ヘルスケアヘルス一般医療用品感染症製薬　 TimeLine: Ansell Launches VivaGel Condom in Canada

2017年04月12日

0